-
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q4 and FY2023 Financial Results
-
Form SC 13G Dianthus Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Dianthus Therapeutics (DNTH) Announces $230 Million Private Placement of Common Stock, Warrants

